Medical Cannabis Shows No Clear Benefit for Anxiety or Depression, Major Study Finds

As cannabis use continues to rise across the U.S., a major international review is challenging one of its most common health claims: that it can treat anxiety and depression.

A new analysis published in The Lancet Psychiatry found no strong scientific evidence that cannabis-based products—including CBD and THC—effectively treat anxiety, depression, or post-traumatic stress disorder (PTSD). The study, led by researchers at the University of Sydney’s Matilda Centre, reviewed 54 clinical trials spanning more than four decades.

“Despite widespread use, the evidence simply isn’t there,” said lead researcher Jack Wilson, emphasizing that many patients are turning to cannabis for mental health conditions without clear clinical support.

What the Science Actually Shows

Across more than 2,400 participants, researchers found that cannabinoids did not produce meaningful improvements compared to placebos in major psychiatric conditions.

At the same time, cannabis use was linked to a higher rate of side effects, raising concerns about its safety in routine treatment.

The findings align with a separate review published in JAMA by Dr. Deepak Cyril D’Souza of the Yale Center for the Science of Cannabis and Cannabinoids, who concluded that cannabis offers limited or no benefit for mental health disorders and may even worsen symptoms in some cases.

Risks, Especially for Young People

Health experts are increasingly concerned about the mental health impact of high-potency cannabis, particularly among adolescents and young adults. According to the National Institute on Drug Abuse, today’s cannabis products contain significantly higher levels of THC than in previous decades.

Research cited in JAMA estimates that up to 30% of recent users may develop cannabis use disorder, while high-THC products can increase the risk of psychosis—especially in people with underlying mental health vulnerabilities.

A large Canadian study led by McMaster University, which tracked 35,000 individuals, found that frequent cannabis users were up to five times more likely to develop anxiety or depression, with the strongest effects seen in younger populations.

Why the Gap Between Belief and Evidence?

Experts say public perception has moved faster than science. The commercialization of cannabis—combined with anecdotal reports of relief—has fueled the idea that it is a safe, natural treatment for mental health.

But clinicians stress that proven treatments already exist. Cognitive behavioral therapy and medications such as selective serotonin reuptake inhibitors (SSRIs) remain first-line, evidence-based options.

A Cautious Path Forward

The consensus among researchers is clear: cannabis should not be routinely recommended for mental health conditions based on current evidence.

For patients, the message is not about fear—but informed decision-making. Mental health symptoms require professional evaluation, and what feels helpful in the short term may carry risks over time.

As research continues, experts urge caution—especially for young people—and emphasize the importance of treatments backed by solid science.